Clinical Trial Update: Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigates cannabidiol as a treatment for severe acute graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: moshe yeshurun | Conditions: Acute-graft-versus-host Disease | Phase 2 | Status: UNKNOWN